Package 70121-1219-1

Brand: doxorubicin hydrochloride

Generic: doxorubicin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 70121-1219-1
Digits Only 7012112191
Product NDC 70121-1219
Product ID 70121-1219_f4a01f55-65d7-401f-ac2f-e1511bf3a429
Description

1 VIAL in 1 CARTON (70121-1219-1) / 25 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2017-02-17
Brand doxorubicin hydrochloride
Generic doxorubicin hydrochloride
Sample Package No

Linked Drug Pages (1)

Doxorubicin Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "f4a01f55-65d7-401f-ac2f-e1511bf3a429", "openfda": {"unii": ["82F2G7BL4E"], "rxcui": ["1790095", "1872062"], "spl_set_id": ["d928625e-c1ef-4f25-8d25-764c8c6aab67"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (70121-1219-1)  / 25 mL in 1 VIAL", "package_ndc": "70121-1219-1", "marketing_start_date": "20170217"}], "brand_name": "Doxorubicin Hydrochloride", "product_id": "70121-1219_f4a01f55-65d7-401f-ac2f-e1511bf3a429", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Anthracycline Topoisomerase Inhibitor [EPC]", "Anthracyclines [CS]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "70121-1219", "generic_name": "Doxorubicin Hydrochloride", "labeler_name": "Amneal Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxorubicin Hydrochloride", "active_ingredients": [{"name": "DOXORUBICIN HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA208888", "marketing_category": "ANDA", "marketing_start_date": "20170217", "listing_expiration_date": "20261231"}